Speaker:

Frances Valencia-Shelton, PhD, D(ABMM), SM(ASCP)^CM

Clinical Infectious Diagnostics Director

Baptist Health System Jacksonville FL

Objectives:

1. Compare the utility of vaginal wet mount testing to molecular testing based on current literature and hospital-based results
2. Devise a strategy for navigating key stakeholder buy in for discontinuing vaginal wet mount testing and clinical workflow considerations for transitioning to a longer turn around time
3. Evaluate system laboratory workflow considerations of transitioning from non-NAAT point of care testing performed outside of the lab to centralized NAAT testing

*SWACM is approved as a Provider of Continuing Education Programs in Clinical Laboratory Sciences by the ASCLS P.A.C.E.® Program. Completion of this program will provide 1.0 contact hour of continuing education. SWACM programs are approved for California-licensed clinical laboratory scientists and personnel. The instructional level of this program is intermediate.